论文信息 - A Phase 1, Open–label Study of Trebananib Combined With Sorafenib or Sunitinib in Patients With Advanced Renal Cell Carcinoma - 字舞流文

A Phase 1, Open–label Study of Trebananib Combined With Sorafenib or Sunitinib in Patients With Advanced Renal Cell Carcinoma

E. Rasmussen | R. Kurzrock | M. Bass | D. Hong | W. Samlowski | N. Vogelzang | Benjamin Wu | M. Gordon | D. Friedland | D. Mendelson | Z. D. Zhong | G. Friberg | Tannir | Léonard | Nizar | J. Appleman